The newly developed COVID-19 vaccines have established a safe profile, yet some
individuals experience a wide range of adverse events. Recently, reactivation of varicella …

(1) Background: Numerous vaccines are under preclinical and clinical development for
prevention of severe course and lethal outcome of coronavirus disease 2019 (COVID-19). In …

Background: Vaccination against SARS-CoV-2 is important for reducing hospitalization and
mortalities. Both Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV …

Background Anaphylaxis, which is rare, has been reported after COVID‐19 vaccination, but
its management is not standardized. Method Members of the European Network for Drug …

Many patients are receiving SARS-CoV-2 vaccinations, which have been associated with a
variety of adverse effects. Cutaneous adverse reactions to SARS-CoV-2 vaccinations have …

Background Vaccination has been promoted to control viral transmission in response to the
coronavirus disease 2019 (COVID-19) pandemic. Cases of new-onset or exacerbation of …

To provide a comprehensive systematic review and meta‐analysis regarding the cumulative
incidence (incidence proportion) of human herpesvirus (HHV) reactivation among patients …

Introduction In this review, cases of herpes zoster (HZ) infection following receipt of COVID‐
19 vaccines will be analyzed. We also present two cases of oral HZ following the COVID‐19 …

Bullous pemphigoid (BP) is an autoimmune bullous disease caused by circulating
autoantibodies toward the hemidesmosomal antigens BP180 and BP230. Cases of BP have …

Although vaccination is widely accepted as an effective method of preventing and controlling
the COVID‐19 pandemic, many people are concerned about possible cutaneous side …